Waljit S. Dhillo

ORCID: 0000-0001-5950-4316 · 14 papers in corpus
2025
Physiological reviews ·doi:10.1152/physrev.00015.2024

Kisspeptin and neurokinin B (NKB) play a key role in several physiological processes including in puberty, adult reproductive function including the menstrual cycle, as well as mediating the symptoms of menopause. Infundibular kisspeptin ne…

review 2024
Endocrine Reviews ·doi:10.1210/endrev/bnad023

Kisspeptin (KP) and neurokinin B (NKB) are neuropeptides that govern the reproductive endocrine axis through regulating hypothalamic gonadotropin-releasing hormone (GnRH) neuronal activity and pulsatile GnRH secretion. Their critical role i…

2024
NPJ digital medicine ·doi:10.1038/s41746-024-01006-x

Infertility affects 1-in-6 couples, with repeated intensive cycles of assisted reproductive technology (ART) required by many to achieve a desired live birth. In ART, typically, clinicians and laboratory staff consider patient characteristi…

review 2022
Journal of neuroendocrinology ·doi:10.1111/jne.13201

The reproductive neuropeptide kisspeptin has emerged as the master regulator of mammalian reproduction due to its key roles in the initiation of puberty and the control of fertility. Alongside the tachykinin neurokinin B and the endogenous …

article 2021
The Journal of clinical endocrinology and metabolism ·doi:10.1210/clinem/dgab108

CONTEXT: The ideal therapy for endometriosis (EM) and uterine fibroids (UFs) would suppress estrogenic drive to the endometrium and myometrium, while minimizing vasomotor symptoms and bone loss associated with current treatments. An integra…

2021
Endocrine Reviews ·doi:10.1210/endrev/bnab015

Reproductive hormones play a crucial role in the growth and maintenance of the mammalian skeleton. Indeed, the biological significance for this hormonal regulation of skeletal homeostasis is best illustrated by common clinical reproductive …

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00656

Introduction: Polycystic ovarian syndrome (PCOS) is a leading cause of female subfertility worldwide, however due to the heterogeneity of the disorder, the criteria for diagnosis remains subject to conjecture. In the present study, we evalu…

2019
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2018-02797

BackgroundHypothalamic kisspeptin/neurokinin B/dynorphin (KNDy) neurones regulate LH pulsatility. It is widely accepted that the menopausal hot flush (HF) consistently synchronizes with the LH pulse, implicating the hypothalamic KNDy neuron…

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00579

Introduction: Ovarian follicle growth is a key step in the success of assisted reproductive treatment, but limited data exists to directly relate follicle growth to recombinant FSH (rFSH) dose. In this study, we aim to evaluate FSH requirem…

2018
Frontiers in endocrinology ·doi:10.3389/fendo.2018.00193

ObjectiveTo identify follicle sizes on the day of trigger most likely to yield a mature oocyte following hCG, GnRH agonist (GnRHa), or kisspeptin during IVF treatment.DesignRetrospective analysis to determine the size of follicles on day of…

2017
Human reproduction (Oxford, England) ·doi:10.1093/humrep/dex253

Study questionCan increasing the duration of LH-exposure with a second dose of kisspeptin-54 improve oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS)?Summary answerA second dose of kisspeptin-54 at 10 h fo…

2015
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2015-2332

ContextIn vitro fertilization (IVF) treatment is an effective therapy for infertility, but can result in the potentially life-threatening complication, ovarian hyperstimulation syndrome (OHSS).ObjectiveThis study aimed to investigate whethe…

2014
The Journal of clinical investigation ·doi:10.1172/jci75730

BackgroundPatients with mutations that inactivate kisspeptin signaling are infertile. Kisspeptin-54, the major circulating isoform of kisspeptin in humans, potently stimulates reproductive hormone secretion in humans. Animal studies suggest…

2013
The oncologist ·doi:10.1634/theoncologist.2012-0416

BackgroundAn association between treatment for gynecological cancers and risk of osteoporosis has never been formally evaluated. Women treated for these cancers are now living longer than ever before, and prevention of treatment-induced mor…